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A modulator of rho family G proteins, rhoGDI, binds these
G proteins via an immunoglobulin-like domain and a flexible
N-terminal arm
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Lu-Yun Lian2,3, Anthony W Segal1, Peter CE Moody2 and Gordon CK Roberts2,3*
Background: The rho family of small G proteins, including rho, rac and
cdc42, are involved in many cellular processes, including cell transformation
by ras and the organization of the actin cytoskeleton. Additionally, rac has a
role in the regulation of phagocyte NADPH oxidase. Guanine nucleotide
dissociation inhibitors (GDIs) of the rhoGDI family bind to these G proteins
and regulate their activity by preventing nucleotide dissociation and by
controlling their interaction with membranes. 
Results: We report the structure of rhoGDI, determined by a combination of
X-ray crystallography and NMR spectroscopy. NMR spectroscopy and
selective proteolysis show that the N-terminal 50–60 residues of rhoGDI are
flexible and unstructured in solution. The 2.5 Å crystal structure of the folded
core of rhoGDI, comprising residues 59–204, shows it to have an
immunoglobulin-like fold, with an unprecedented insertion of two short
b strands and a 310 helix. There is an unusual pocket between the b sheets of
the immunoglobulin fold which may bind the C-terminal isoprenyl group of rac.
NMR spectroscopy shows that the N-terminal arm is necessary for binding
rac, although it remains largely flexible even in the complex. 
Conclusions: The rhoGDI structure is notable for the existence of both a
structured and a highly flexible domain, both of which appear to be required
for the interaction with rac. The immunoglobulin-like fold of the structured
domain is unusual for a cytoplasmic protein. The presence of equivalent
cleavage sites in rhoGDI and the closely related D4/Ly-GDI (rhoGDI-2)
suggest that proteolytic cleavage between the flexible and structured regions
of rhoGDI may have a role in the regulation of the activity of members of this
family. There is no detectable similarity between the structure of rhoGDI and
the recently reported structure of rabGDI, which performs the same function
as rhoGDI for the rab family of small G proteins.
Introduction
The rho family of ras-related G proteins (GTPases)
includes the isoforms of rho, rac, cdc42 and TC10 [1]. The
proteins rac, rho and cdc42 are all involved in the reorgani-
zation of the actin cytoskeleton in response to external
stimuli [2–4]. These proteins also have roles in cell trans-
formation by ras, in cytokinesis, in focal adhesion forma-
tion and in the stimulation of stress-activated kinase [4–7].
The immediate downstream target of these G proteins is
usually a serine/threonine kinase [7]. Additionally, rac has
a specific role in the activation of the phagocytic NADPH
oxidase [8,9]. 
Like ras, members of the rho family of GTPases act as
molecular switches by virtue of a conformational change
between the GTP- and GDP-bound forms. The inherent
rates of GTP hydrolysis and nucleotide dissociation are
slow, and proteins have been described that accelerate
hydrolysis (GTPase-activating proteins; GAPs) and cat-
alyze exchange of GTP for GDP (guanine nucleotide
exchange factors; GEFs) [1,4]. There are also two known
groups of guanine nucleotide dissociation inhibitors
(GDIs) that inhibit the release of guanine nucleotides
from members of the rab family (rabGDI and its homo-
logues) and the rho family (rhoGDI and its homologues).
There is no significant sequence homology between pro-
teins of the two groups of GDIs, and these proteins are of
very different sizes — rabGDIs are proteins of at least 450
residues, whereas rhoGDIs are only about 200 residues
[1]. Three human homologues of rhoGDI have been
reported. The form studied here, rhoGDI (rhoGDI-1)
[10], is found in a broad range of cells and is active towards
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all forms of rho, rac and cdc42. D4-GDI or Ly-GDI
(rhoGDI-2) [11,12] is particularly abundant in haematopo-
etic cells and also has a broad range of activity toward the
rho family of proteins. The most recently identified of
these proteins, rhoGDI-3 [13], is specifically active
towards rhoB and rhoG and, unlike the other two forms
which are cytoplasmic, it is associated with the membrane
or possibly the cytoskeleton [13].
Most small G proteins undergo post-translational modifi-
cation by transfer of farnesyl or geranylgeranyl groups to
cysteines at or near their C termini. In the case of the rho
family, the enzyme geranylgeranyl transferase I recognizes
the CXXL sequence and transfers a geranylgeranyl group
to the cysteine residue. The G protein is further modified
by cleavage of the XXL sequence and the formation of a
methyl ester at the now isoprenylated C-terminal cys-
teine. The rab family of G proteins contains the sequence
CC or CXC at the C terminus, and both cysteines are
modified by addition of a geranylgeranyl group by ger-
anylgeranyl transferase II [14,15]. Interaction of both
rhoGDI [16] and rabGDI [17] with their cognate G pro-
teins is dependent on the geranylgeranylation of the
C-terminal cysteine(s) of the G protein. In the cell, many
of the targets of the G proteins are in the membrane and
G protein isoprenyl modification appears to mediate mem-
brane binding. Cytosolic G proteins of the rho and rab
families normally exist in the cell bound to their cognate
GDIs, and the GDIs can actively remove their G proteins
from the membrane [18–20]. This role of GDI in parti-
tioning of the G proteins between membrane and cytosol
may be physiologically more important than the inhibition
of nucleotide dissociation. 
In this paper, we describe the structure of rhoGDI. This
protein is notable for the existence of both a structured
and a highly flexible domain; the structured domain com-
prises an immunoglobulin-like fold, which is unusual for a
cytoplasmic protein. There is no detectable similarity
between the structure of rhoGDI and the recently
reported structure of rabGDI, which performs the same
function for the rab family of small G proteins. Both the
structured and flexible domains of rhoGDI appear to be
required for its interaction with rac, and comparison with
the closely related D4/Ly-GDI (rhoGDI-2) suggests that
proteolytic cleavage between the flexible and structured
regions may have a role in the regulation of the activity of
members of the rhoGDI family. 
Results and discussion
RhoGDI consists of a flexible N-terminal arm and an ordered
domain
The 15N–1H HSQC spectrum of rhoGDI (Fig. 1a) shows
that the cross-peaks can be divided into two groups,
according to their linewidths. Between 50 and 60 of the
backbone amide cross-peaks (predominantly in the region
1H 7.7–8.6ppm, 15N 115–129ppm) are much narrower
than the remainder, as are many of the sidechain amide
cross-peaks (1H 6.7–7.7ppm, 15N 111–114ppm). These
narrow peaks can be selectively observed by plotting the
spectrum with a higher threshold (Fig. 1b). These sharp
resonances must arise from residues that have substantial
local mobility. Selective proteolysis of rhoGDI with
trypsin gave a stable protease-resistant domain of about
17kDa, identified by N-terminal sequencing as starting at
residue 59 of rhoGDI. The 15N–1H HSQC spectrum of
this fragment (Fig. 1c) lacks most of the sharp cross-peaks
seen with the full-length protein; the remaining cross-
peaks appear in the same positions as in the intact protein,
indicating that the structure of the 17kDa fragment is
essentially the same as that of the corresponding portion
of the intact molecule. This demonstrates that rhoGDI
has two structural domains, a flexible domain comprising
the N-terminal ∼60 residues of the protein and an ordered
or folded domain comprising the remaining ∼140 residues. 
Crystal structure of the folded domain of rhoGDI
The folded domain produced by proteolysis of rhoGDI
with trypsin (comprising residues 59–204 of the intact
protein) was crystallized from ammonium sulphate, and
the structure was solved to a resolution of 2.5 Å by multi-
ple isomorphous replacement with anomalous scattering
(see Materials and methods; Table 1). A portion of the
electron-density map of the rhoGDI structure is shown in
Figure 2. The asymmetric unit contains three copies (A,
B, C) of the rhoGDI molecule; these each have essentially
identical structures except for the first nine amino acids
(Fig. 3a). The rms differences (calculated using LSQMAN
[21]) between all atoms in residues 68–203 are: B to A,
0.68Å; C to A, 0.71 Å; C to B, 0.58 Å. The first nine
residues are in different conformations in molecules A and
B (Fig. 3a; the rms difference for residues 59–67 is 12.35 Å
when the molecules are superposed using residues
68–203) and are not ordered in molecule C. The model
contains all residues from Val59 of rhoGDI, except for
residues 59–67 in molecule C and for the C-terminal
residue (Asp204) in all three molecules, which appears to
be disordered. There are also 191 waters and 9 sulphates.
The structure of rhoGDI consists of nine b strands in two
antiparallel sheets, forming a b sandwich, and one two-
turn 310 helix (Figs 3a,b). In the orientation shown in
Figure 3, the top sheet consists of strands b2 (residues
87–89), b1 (70–78), b4 (111–118) and b7 (156–159), and
the bottom sheet of strands b3 (102–105), b9 (190–199),
b8 (173–183), b5 (125–134) and b6 (137–144). The short
310 helix is packed against the edge of the bottom b sheet.
The structure of rhoGDI was compared with known
protein structures using the program DALI [22]. The 52
proteins that gave statistically significant structural align-
ments nearly all had immunoglobulin-like folds; these
consist of a core of seven b strands in two sheets forming
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an antiparallel b sandwich with a Greek key topology [23].
In rhoGDI, the b strands that correspond to those in the
immunoglobulin fold are b1, b4, and b7 in the first sheet
and b9, b8, b5 and b6 in the second, shown in green and
red, respectively, in Figure 3b. The topology of the
immunoglobulin-like core of rhoGDI corresponds to the s-
type of immunoglobulin-like folds as defined by Bork et
al. [24]; this is a variation of the classical constant domain
fold in which the d strand is swapped to the other sheet
and renamed c′. Proteins that also show this topology
include fibronectin repeats, CD4 domains 2 and 4, CD2
domains and two domains of Escherichia coli b-galactosi-
dase; these were among the most significant matches
given by DALI. The classical immunoglobulin fold has a
disulphide bridge between strands b and f (b4 and b7 in
the case of rhoGDI). As expected for a cytosolic protein,
there is no disulphide bridge in rhoGDI. Some known
s-type immunoglobulin domains do have the b–f strand
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Figure 1
15N–1H HSQC spectra of intact and
truncated rhoGDI. (a) Spectrum of intact
rhoGDI. Between 50 and 60 of the backbone
amide cross-peaks and many of the sidechain
amide cross-peaks have linewidths much
narrower than the remainder. (b) The same
spectrum plotted with a higher threshold, and
thus showing only the sharp cross-peaks. (c)
Spectrum of truncated rhoGDI containing
residues 59–204, showing the loss of most of
the sharp cross-peaks, while the remainder of
the cross-peaks appear in the same positions. 
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disulphide bond (e.g. CD4 domain 2), whereas others
have an unusual a–g strand disulphide bond (e.g. neu-
roglian domain 2), and some have both (CD2 domain 2).
S-type domains that, like rhoGDI, lack a disulphide bond
include growth hormone receptor domain 2 and
fibronectin [24]. There is only one cysteine in the trun-
cated rhoGDI, which lies at the end of strand a. The struc-
ture of rhoGDI contains an unprecedented insertion
(residues 80–110 shown in blue in Fig. 3b), replacing a
hairpin loop between strands a and b (equivalent to b1
and b4 in rhoGDI) in the classical immunoglobulin fold.
This insertion consists of two short b strands (b2 and b3)
and a 310 helix; each of these b strands extends one of the
two sheets.
Figure 3c shows the structure of the ordered domain
coloured by the average mainchain B factors. (The
sidechain and overall B values follow a similar pattern,
but with more variation due to surface sidechains.) Most
of the b strands have low B values, including the two
short inserted strands b2 and b3. Strand 6 is somewhat
more mobile, as is the 310 helix; both these elements lie
on the edge of the structure. The N and C termini are
highly mobile, and there is a particularly disordered,
charged loop from Asp183 to Lys186. 
Figure 4 indicates the buried residues that form the
hydrophobic core. Mutagenesis studies in which the
C terminus of rhoGDI was progressively truncated have
shown that one or more of the residues between 197 and
200, but not between 201 and 204, are essential for
rhoGDI binding to cdc42 (Fig. 5; [25]). This can be
understood from the structure of rhoGDI, which shows
that Ile198, in b strand 9, forms part of the hydrophobic
core of the folded domain; in the truncated rhoGDI
(residues 1–197), the structured domain is thus unlikely
to be fully folded, explaining its inability to bind cdc42.
Residues in the insertion (residues 80–110) clearly form
part of the hydrophobic core. In particular, the two trypto-
phans 192 and 194 in b strand 9 make contact with
several of the buried residues in the insertion (Leu88,
Phe97 and Phe102). It is clear from the B factors and from
consideration of the residues involved in the hydrophobic
core that the unusual insertion into the immunoglobulin
fold is an integral and stable part of the structure of
rhoGDI. 
There is no detectable similarity between the structure of
rhoGDI reported here and the recently reported structure
of rabGDI [26], which performs the same function for G
proteins of the rab family. The latter is a much larger
protein of 450 residues, which has structural similarities
to FAD-dependent flavoproteins, although there is no
known role for FAD in its function. 
A pocket in the rhoGDI molecule may bind the C-terminal
isoprenyl group of G proteins
Inspection of the accessible surface of the folded domain
of rhoGDI (Fig. 5a) reveals a large cavity (12 × 8 × 10 Å)
between the two b sheets of the immunoglobulin fold.
Although this pocket is largely hydrophobic, it contains a
region of negative potential. The T and B cell homologue
of rhoGDI, rhoGDI-2 (D4/Ly-GDI), has a sequence very
similar to that of rhoGDI-1 (Fig. 4), but it has a 10–20-
fold lower affinity than rhoGDI-1 for isoprenylated cdc42.
A single mutation in rhoGDI-2, Asn177→Ile (rhoGDI
numbering), substantially explains this difference in
affinity [25]. Residue 177 lies on the surface of the
protein, in the pocket (Fig. 5b), and the effect of substitu-
tion at this position on the affinity for cdc42 indicates that
the pocket plays an important role in G-protein binding. 
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Table 1
Phasing and refinement statistics for rhoGDI.
Data Set
Native Mercury Selenium
Wavelength (Å) 0.977 0.832 0.977
Resolution (Å) 2.7 3.2 2.5
Observations 96 325 66 276 16 1161
Unique observations 17 218 9729 20 345
Completeness (%) 99.7 92.8 92.9
Redundancy 5.6 6.8 7.9
I/s 22.5 10.2 25.5
Rsym* 0.081 0.094 0.071
Ranom† 0.066 0.036
Number of sites 3 9
Rcullis‡ 0.69 0.89
Rcullis (anom)‡ 0.78 0.94
Phasing power§ 1.72 0.79 
Highest resolution shells
Resolution range 2.8–2.7 3.31–3.2 2.59–2.5
Completeness (%) 100 95.6 95.3
Median redundancy 5 7 11
Rsym* 33.6 18.1 26.4
I/s 6.6 10.3 8.7
Refinement statistics¶
Resolution (Å) 8–2.7 8–2.5
Number of atoms 3663 3663 
Rcryst (%)# 24.0 22.5 
Rfree (%)# 31.0 29.8
Rms bond lengths (Å) 0.012
Rms bond angles (°) 2.0
Cell parameters are a = b = 156.57, c = 132.50, in space group R32
(155) hexagonal setting. *Rsym = ΣΣ| 〈Ι〉– Ij /Σ〈Ι〉, where Ij is the
observed intensity and 〈Ι〉 is the mean intensity.
†Ranom = S(〈I〉 – 〈I +〉+〈I〉 – 〈I –〉)/Σ〈I〉. ‡Rcullis = (lack of
closure)/(isomorphous difference); Rcullis (anom) = (lack of
closure)/(anomalous difference) for acentric terms. §Phasing
power = ΣFch / Σ [ |Fopexp(iθp) + Fchexp(iθc)| – Foph, where Fch and θc are the
calculated heavy-atom amplitude and phase, Fop and F
o
ph are the
observed amplitudes for the protein and the heavy-atom derivative and
θp is the MIR phase and the sum is over all observations. ¶Refinement
was carried out using the selenium data set; statistics for the native
data set are the result of using the native data set and changing the
seleniums to sulphurs, not the result of an independent refinement.
#Rx = Σ |F
o
p – F
c
p |; for x = cryst the sum is over the 95% of data used for
refinement, for x = free this sum is over the remaining 5% of data. 
Geranylgeranylation of the G protein is essential for tight
binding to rhoGDI [16,27], so recognition of the isoprenyl
group is likely to be part of the function of rhoGDI. We
suggest that this cavity in the surface of rhoGDI may be
involved in binding the isoprenyl group of post-transla-
tionally modified rho, rac and cdc42, and that the ordered
domain as a whole interacts with the C-terminal region of
the G proteins. This C-terminal region was shown to be
disordered in the recently determined structure of rac1a
(M Hirshberg and G Dodson, personal communication)
and in general has been removed by proteolysis or engi-
neering from the G-protein structures, determined so far
(e.g. for rac1, [28]). Since the N-terminal structure is not
known and is probably very flexible, it is difficult to model
the complex of rhoGDI with a G protein from the cur-
rently available structures. The cavity in rhoGDI is the
right size to accommodate a geranylgeranyl group
(Fig. 4a), and the regions of negative electrostatic poten-
tial in and near the cavity might interact with the stretch
of basic amino acids that immediately precede the iso-
prenylated cysteine in the G-protein sequence. Electron-
density maps from crystals soaked in isoprenyl derivatives
of cysteine or from crystals grown in the presence of such
derivatives showed no density for an isoprenyl group.
However, in the crystal form reported here (which was the
only one was obtained), Leu170 from an adjacent copy of
the molecule is inserted into the cavity (Fig. 5c), prevent-
ing the cavity being occupied by an isoprenyl group in this
crystal form. Addition of N-acetyl-S-farnesylcysteine to
either full length or trypsin-truncated rhoGDI did,
however, produce a limited number of specific changes in
the HSQC spectrum of the protein. These changes all
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Figure 2
A region of the electron-density map of crystal
structure of rhoGDI containing parts of three
of the b strands. Residues 131, 177, 181,
190 and 193 are labelled to assist orientation.
(a) Stereo pair of the original multiple
isomorphous replacement solvent-flattened
electron-density map (MIR figure of
merit = 0.39; and after solvent flattening with
the program dm is 0.84). (b) Stereo pair of
the final 2Fo–Fc map, with the final atomic
model superimposed in thick black lines.
Drawn with BOBSCRIPT (R Esnouf’s
modification of MOLSCRIPT [42]).
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involved resonances from the ordered domain, showing
that the isoprenyl group does interact with the structured
region of rhoGDI in solution (LYL, RB, IB, NK, GCKR,
unpublished results).
The calycin family (lipocalins, avidins and fatty acid
binding proteins) also bind largely hydrophobic ligands in
a cavity between their b sheets [29]. Although the calycins
all have a 310 helix, rhoGDI does not share the structural
features common to this family of proteins, which consist
of two b sheets of at least four strands each, at roughly 90°
to each other. Four strands of one sheet and two of the
other superimpose very closely throughout the family [30].
There is some similarity in the size and amino acid com-
position of the cavities in the two protein types, for
example both contain several aromatic residues. The more
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Figure 3
Structure of the ordered domain of rhoGDI.
(a) Stereo pair of the a-carbon trace of
molecules A (black), B (red) and C (blue),
superposed using LSQMAN [21]. The
a-carbon positions of chain A are numbered.
(b) Stereo pair of one copy of the domain.
Elements of secondary structure are shown by
arrows for b strands and a ribbon for the short
310 helix. The seven strands corresponding to
the two b sheets of the immunoglobulin fold
are shown in red and green. The insertion into
the immunoglobulin fold, shown in blue,
consists of two short b strands, one extending
from each sheet, and a 310 helix. The
sidechain of Ile177 is shown in yellow as a
ball-and-stick representation, to indicate the
location of the cavity (see Fig. 5). (Figure was
drawn using the program MOLSCRIPT [42].)
(c) Structure of rhoGDI coloured by the
average mainchain B values of each residue.
Bright blue represents a B factor of 5 and one
of 40 is bright red. Intermediate values are on
a gradual scale of colour passing from blue
through white to red. Drawn with
BOBSCRIPT.
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open rhoGDI cavity may be related to a clear functional
difference between rhoGDI and the calycins —the
hydrophobic ligand of rhoGDI, unlike those of the
calycins, is attached to a protein, which could provide
amino acids to close the open face of the cavity.
The function of the flexible N-terminal domain
Addition of recombinant non-isoprenylated rac1 to 15N-
labelled rhoGDI led to specific changes in the chemical
shifts of a limited number of cross-peaks in the 15N–1H
HSQC spectrum. These changes involve both some of the
sharp resonances from the N-terminal region and some of
the resonances from the structured domain (Fig. 6). When
the experiment was repeated with truncated rhoGDI, the
spectrum of rhoGDI was unaffected (data not shown),
demonstrating that the N-terminal domain is required for
binding rac. Recognition of rac by rhoGDI thus involves
both domains of the rhoGDI molecule. 
In discussing the structure of rabGDI, Schalk et al. sug-
gested that the complex with rab might be formed by an
extended b sheet [26], by analogy to the only
G-protein–effector structure reported to date, the rap–raf
complex [31]. In the latter structure, the main interaction is
between the edge of the effector b strand of rap1A and the
edge of a b strand from the raf domain. Although this is an
edge-to-edge b-sheet interaction, many of the hydrogen
bonds are between sidechains and most of the mainchain
interactions expected in a b sheet are missing; there is also
an interaction between the helix in the raf protein and the
same effector b strand of rap. There are several exposed b-
sheet edges in the rhoGDI structure (Fig. 5b), but it
remains to be seen whether this type of sheet–sheet inter-
action is general. The sequence in rhoGDI (residues
32–35; Gln-Lys-Ser-Ile) most similar to the ras-binding
region of raf (66–69; Gln-Arg-Thr-Val) lies in the flexible
N-terminal region (Fig. 4). If the effector region of the
G protein is involved in binding to rhoGDI, the N-termi-
nus of rhoGDI could wrap round to bind the effector
region of rac or rho, while the immunoglobulin-like domain
binds the C-terminus. From the structure of rac-1 [28] and
a model of cdc42 [32], it is unlikely that the ordered
domain could interact both with the C-terminus and with
the effector loop, because they are likely to be separated
by too large a distance.
The first 25 residues of full length rhoGDI, which show
little sequence conservation between rhoGDI-1 and
rhoGDI-2 (Figure 4), are not required for binding to iso-
prenylated cdc42 [25]. This suggests that the interaction
with rac probably involves residues 26–58 (including the
residues 32–35, noted above), and the first 25 residues
may remain mobile in the complex. Indeed, the HSQC
spectrum shows that many of the sharp cross-peaks remain
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Figure 4
Alignment of the amino acid sequences of
rhoGDI-1 (rhoGDI), rhoGDI-2 (D4/Ly-GDI)
and rhoGDI-3, carried out using the
CLUSTAL W program [43], summarizing
some of the known biochemical information.
The secondary structure is shown as b for a
b strand and 3 for the 310 helix. Buried
residues are indicated by B; the criterion used
was that the solvent accessible area, using a
probe sphere of 1.4 Å in the CCP4 programs
AREAIMOL and RESAREA, should be less
than 30 Å2 (20 Å2 for glycines) in all three
copies. The trypsin cleavage site in rhoGDI
reported in this paper and the Cpp32 and ICE
cleavage sites in Ly(D4)-GDI [33,34] are
marked. The residues that can be deleted
from rhoGDI-1 without loss of binding activity
are in lower case, and those whose deletion
causes loss of activity are in bold. The single
residue difference between rhoGDI-1 and
rhoGDI-2, which accounts for most of the
difference in their affinities for cdc42 [25], is
in the smaller box. The possible effector-
binding region discussed in the text is in the
larger box.
rhoGDI-1 (human)    	   ma eqeptaeqla qia....aen e.e....... .dehsvNYKP  29
rhoGDI-3 (mouse) 	MLGLDACELG EQLLELLRLA LCARVLLADK DGESTPSDEV LDEIVPEYQA  50
rhoGDI-2 (human) 	       .MT EKAPEPHVEE DDD......D E......... .LDSKLNYKP  26
                                                 Trypsin        
	 	 	 	 	 	 	 	 	 	 	 	     Cpp32
buried residues                                                  B BBBBBB B
secondary structure 	                                            βββββββββ
rhoGDI-1 (human) 	PAQKSIQEIQ ELDKDDESLR KYKEALLGRV AVSADPNVPN VVVTGLTLVC  79
rhoGDI-3 (mouse) 	PGKKSMLAIW QLDPGDVSLV KYKQALLGPL PPIMDPSLPN VQVTRLTLLT 100
rhoGDI-2 (human) 	PPQKSLKELQ EMDKDDESLI KYKKTLLGDG PVVTDPKAPN VVVTRLTLVC  76
                                                  ICE
buried residues        B   B B  B      B     B B   B  B B BBB B     B BB BB
secondary structure 	       βββ      33333   ββββ      ββββββββ       βββββ
rhoGDI-1 (human) 	SSAPGPLELD LTGDLESFKK QSFVLKEGVE YRIKISFRVN REIVSGMKYI 129
rhoGDI-3 (mouse) 	EQAPGPIIMD LTGDLDALKN QVFVLKEGIE YKVKITFKVN KEIVSGLKCL 150
rhoGDI-2 (human) 	ESAPGPITMD LTGDLEALKK ETIVLKEGSE YRVKIHFKVN RDIVSGLKYV 126
buried residues      BBB            B B            B  B    B      B   B B B
secondary structure 	 βββββ  βββ βββββ            ββββ               βββββββ
rhoGDI-1 (human) 	QHTYRKGVKI DKTDYMVGSY GPRAEEYEFL TPVEEAPKGM LARGSYSIKS 179
rhoGDI-3 (mouse) 	HHTYRRGLRV DKAIFMVGSY GPRAQEYEFV TSVEEAPRGA LARGLYVVRS 200
rhoGDI-2 (human) 	QHTYRTGVKV DKATFMVGSY GPRPEEYEFL TPVEEAPKGM LARGTYHNKS 176
buried residues       BBB         B BBBBB
secondary structure 	 ββββ       ββββββββββ      
rhoGDI-1 (human)     RFTDDDKTDH LSWEWNLTIK Kdwkd 204
rhoGDI-3 (mouse) 	LFTDDDRLNH LSWEWHLHVC QDWKD 225
rhoGDI-2 (human) 	FFTDDDKQDH LSWEWNLSIK KEWTE 201
sharp on addition of rac, and hence that the N-terminal
region retains a large degree of flexibility in the complex.
The rhoGDI-2 protein has been shown to be cleaved
specifically in the N-terminal region by two members of
the ICE/CED-3 family of cysteine proteinases (Fig. 4)
[33,34]. In particular, cleavage by IL-1b-converting
enzyme (ICE) leads to inactivation of the GDI [33], and it
has been proposed that cleavage and inactivation of
rhoGDI-2 may have a regulatory role in inflammation and
apoptosis [33,34]. It is striking that the ICE cleavage site
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Figure 5
Isoprenyl-binding pocket of rhoGDI. (a)
GRASP [44] representation of the accessible
surface of the ordered domain of rhoGDI.
Regions of positive and negative electrostatic
potential are shown in blue and red,
respectively. The cavity is near the centre of
the surface (marked with an arrow), close to a
region of negative potential.
Geranylgeranylcysteine is shown below the
structure to allow its size to be compared with
that of the cavity. (b) Stereo pair of the
structure of rhoGDI in the same orientation as
(a). Colour scheme and secondary structure
elements are depicted as for Figure 3b. (c)
Stereo pair of the mainchain trace of molecule
A (blue) and residues 164–177 of a symmetry
generated copy of molecule C (red). The
sidechain atoms of Leu170 from the copy of
molecule C are shown as red spheres, and
the sidechain atoms of residues 77, 102, 104,
110, 112, 128, 130, 132, 139, 140, 142,
144, 163, 165, 171, 175, 179, 194, 196 and
198 of molecule A are drawn as blue spheres
to show the cavity. The red of the inserted
leucine residue 170 (molecule C) can be seen
in the gaps which result from the fact that the
mainchain atoms are not drawn as spheres.
Drawn using MOLSCRIPT [42]. 
S-geranylgeranyl- 
cysteine
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is in a position exactly equivalent, in terms of the sequence
alignment in Figure 4, to the site of trypsin cleavage in
rhoGDI-1 reported here (Fig. 4). Given the strong
sequence similarity between rhoGDI-1 and rhoGDI-2, it is
very likely that the N-terminal region of rhoGDI-2 is also
flexible, and is also essential for binding to rho family
G proteins. It remains to be seen whether cleavage at this
site has any physiological significance as a method of
rhoGDI-1 (as well as rhoGDI-2) inactivation in vivo.
Biological implications
Members of the rho family of ras-related GTPases,
including rho, rac and cdc42, are involved in the reorga-
nization of the actin cytoskeleton in response to external
stimuli, in cell transformation by ras, in cytokinesis and
in focal adhesion formation. Additionally, rac has a spe-
cific role in the activation of the phagocytic NADPH
oxidase. There are two known groups of guanine
nucleotide dissociation inhibitors (GDIs) that inhibit
release of guanine nucleotides from members of the rab
family (rabGDI and its homologues) and the rho family
(rhoGDI and its homologues). These two groups of
GDIs show no sequence homology with each other.
GDIs can also control the partitioning of their cognate G
proteins between the membrane and cytosol.
Our studies of rhoGDI reveal that it consists of two
regions, a flexible N-terminal region and an ordered
immunoglobulin-like domain, and we report the 2.5 Å
crystal structure of the ordered domain. The structure of
rhoGDI has no similarity to that of rabGDI. The
ordered region of rhoGDI is responsible for binding to
the C-terminal isoprenyl group of the post-translationally
modified GTPases. We identify a possible site for this
interaction, in a cavity between the b sheets of the
ordered domain. This cavity provides a structural expla-
nation of how rhoGDI controls the partitioning of the
G proteins between the membrane and the cytosol, sug-
gesting that it competes with the membrane for binding
the G protein isoprenyl group. Both the folded domain
and the flexible N-terminal arm are essential for the rac-
binding function of rhoGDI. The flexible domain may
interact with the nucleotide-binding loop of the G
protein, preventing dissociation of the nucleotide. A com-
parison of rhoGDI with the closely related D4/Ly-GDI
(rhoGDI-2) reveals that proteolytic cleavage between
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Figure 6
The 15N–1H HSQC spectra of intact rhoGDI
alone (black) and in the presence of an
equimolar amount of rac1 (red). Examples of
resonances affected by rac binding are
indicated by arrows.
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the flexible and structured regions of rhoGDI occurs at
an equivalent position to cleavage of rhoGDI-2. Because
cleavage of rhoGDI-2 leads to its inactivation, cleavage
of rhoGDI may have a role in regulating the activity of
members of the rhoGDI family — and hence in the regu-
lation of G proteins of the rho family.
Materials and methods 
Purification and crystallization
A GST–rhoGDI fusion protein was expressed in E. coli using the
vector pGEX2T and purified using glutathione Sepharose; rhoGDI was
released by thrombin treatment of the fusion protein bound to the
column. Full-length material was further purified by anion-exchange
(MonoQ) and gel-filtration chromatography. The truncated protein was
prepared by treatment with 0.001% (w/v) trypsin for 2 hours at 4°C,
the reaction was stopped by addition of 0.5 mM PMSF and the protein
purified by gel filtration. N-terminal sequencing was carried out by the
Leicester Protein and Nucleic Acid Chemistry Laboratory. Crystals
were grown by the hanging-drop method. Equal volumes of the precipi-
tant well (2 M ammonium sulphate in 0.1 M Tris pH 8.5, 1 mM DTT,
1 mM sodium azide) and the protein stock (10 mg ml–1 protein in 5 mM
Tris pH 8.5, 1 mM DTT, 1 mM sodium azide) were mixed and placed on
a coverslip sealed over 1 ml of precipitant mixture. Crystals grew at all
temperatures tried between 4 and 22°C; the final data sets were from
crystals grown at 4°C. The best crystals used for final data collection
grew to 0.8 × 0.3 × 0.3 mm.
For heavy-atom soaks, crystals were transferred to a mother liquor of
2 M ammonium sulphate in 0.1 M Tris, pH 8.5, 1 mM sodium azide, at
room temperature. They were transferred to 2 M ammonium sulphate in
0.1 M Tris, pH 8.5, 1 mM sodium azide, 25% glycerol for freezing. The
crystals could be stored unfrozen for several weeks in the glycerol
mixture without significant deterioration. Selenomethionine protein
(rhoGDI) was produced by growth of a methionine auxotroph in
medium supplemented by selenomethionine. 15N-labelled protein was
prepared by growth in minimal medium containing 15NH4Cl as the sole
nitrogen source. Recombinant rac1 was also expressed in E. coli as a
GST fusion and purified in a similar manner.
Crystal structure determination
Potential heavy-atom derivatives were screened using the protein crys-
tallography facilities at Leicester (Rigaku RU200HB rotating anode
generator and Raxis IIc image plate system). Final diffraction data was
collected at 100K on beamline BW7A at EMBL DESY Hamburg at
wavelengths chosen to optimize the anomalous scattering (Table 1).
The data were integrated and averaged with DENZO and
SCALEPACK [35]. The three mercury sites were found from the anom-
alous difference data using SHELX [36]. The CCP4 [37] package was
used to obtain the selenium sites by difference Fourier calculations. All
nine selenium sites arose as the top nine sites in a difference Fourier of
the selenium–native differences. The initial map from MLPHARE had a
figure of merit of 0.39. Solvent flattening and histogram matching using
the program dm [38] gave an interpretable map and improved the
figure of merit to 0.84. Averaging between copies in the asymmetric
unit was not used. A model was manually built into one copy using the
program O [39]. The noncrystallographic symmetry (ncs) was used to
generate the other two copies of this model. This model gave an initial
R factor of 40% (Rfree of 42%) Refinement was carried out against the
selenomethionine data set, using selenium scattering factors, as this
was to the highest resolution. The ncs restraints were removed early in
the refinement, as it was clear there were significant differences in the
N terminal region. Alternate cycles of refinement using the restrained
geometry regularization (prepstage), simulated annealing (slow cool) or
B-factor refinement protocols in X-PLOR [40] and manual rebuilding
and addition of water molecules and sulphate ions using Fo–Fc maps in
O was continued until no further interpretation of the largest remaining
differences was possible. This gave a final R factor of 22.5% (Rfree of
29.8%). The structure was also checked by recalculating the R factors
using the native data and sulphur scattering factors. This only gave a
small increase in R factors (Table 1) without refining any parameters
against this data. Analysis of the structure using PROCHECK [41]
confirmed that the final geometry was at least as good as expected for
a structure of this resolution and that all the residues lay in the allowed
regions of the Ramachandran plot (Fig. 7). The overall G factor was 0.1
in PROCHECK [41]
NMR spectroscopy
Samples contained 0.1–0.5 mM uniformly 15N-labelled rhoGDI in
20 mM phosphate, pH 6.3. All experiments were carried out at 293K on
Bruker DMX500 and AMX600 spectrometers. Two-dimensional
15N–1H HSQC (or HMQC) spectra were acquired with gradient water
suppression. Unlabelled rac1, N-acetyl-S-farnesylcysteine or N-acetyl-
S-geranylgeranylcysteine were added in amounts equimolar with
rhoGDI. Geranylgeranylcysteine caused nonspecific line-broadening
and precipitation.
Accession numbers
The coordinates have been deposited in the Protein Data Bank with an
accession code of 1RHO.
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